Proteomics

Dataset Information

0

Multi-omics characterization of MEK inhibitor resistant pancreatic cancer based on a genetically engineered mouse model-derived in vitro system


ABSTRACT: Tumor heterogeneity and therapy resistance are hallmarks of pancreatic ductal adenocarcinoma (PDAC). Emerging evidence supports treatment-induced resistance to be a multifactorial process mediated by cellular plasticity involving epigenetic regulation. Here, we used a multi-omics approach to analyze in detail molecular mechanisms underlying MEK inhibitor (MEKi) resistance. Therefore, we characterized different cell stages (parental, MEKi resistant, reverted after different passages of drug withdrawal) in primary cell lines derived from a genetic PDAC mouse model, thereby minimizing inter-individual heterogeneity that could distort genome-wide analyses.

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Primary Cell, Cell Culture, Pancreatic Ductal Carcinoma Cell

DISEASE(S): Pancreatic Ductal Adenocarcinoma

SUBMITTER: Kathrin Elisabeth Witzke  

LAB HEAD: Barbara Sitek

PROVIDER: PXD018093 | Pride | 2024-01-26

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
OEI28227.mgf Mgf
OEI28227.msf Msf
OEI28227.mzid.gz Mzid
OEI28227.pride.mgf.gz Mgf
OEI28227.pride.mztab.gz Mztab
Items per page:
1 - 5 of 108
altmetric image

Publications


<h4>Background</h4>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor prognosis. It is marked by extraordinary resistance to conventional therapies including chemotherapy and radiation, as well as to essentially all targeted therapies evaluated so far. More than 90% of PDAC cases harbor an activating KRAS mutation. As the most common KRAS variants in PDAC remain undruggable so far, it seemed promising to inhibit a downstream target in the MAPK pathway such as MEK1/2, but u  ...[more]

Similar Datasets

2024-04-22 | E-MTAB-13951 | biostudies-arrayexpress
2013-05-01 | E-GEOD-43623 | biostudies-arrayexpress
2013-11-01 | E-GEOD-50881 | biostudies-arrayexpress
2023-03-29 | GSE197555 | GEO
2024-01-26 | PXD039590 | Pride
2017-05-31 | E-MTAB-5775 | biostudies-arrayexpress
2024-07-19 | E-MTAB-13454 | biostudies-arrayexpress
2022-05-01 | GSE173577 | GEO
2023-12-31 | GSE138481 | GEO
2023-12-31 | GSE138477 | GEO